Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : COVID-19 Jabs Supplied to Canada, Mexico From US Before Inspection of Plant Operations

07/29/2021 | 10:51am EDT


ę MT Newswires 2021
All news about ASTRAZENECA PLC
02:29pTHE LATEST : Johnson to Bolsonaro: vaccines save lives
AQ
11:12aEuropean ADRs Move Sharply Lower in Monday Trading
MT
11:07aASTRAZENECA : Imfinzi plus chemotherapy tripled patient survival at three years ..
AQ
11:07aDAIICHI SANKYO : Enhertu reduced the risk of disease progression or death by 72%..
AQ
11:07aDAIICHI SANKYO : Enhertu demonstrated robust and durable tumour response of 54.9..
AQ
10:25aASTRAZENECA : SVB Leerink Adjusts AstraZeneca's PT to $71 from $69, Keeps Outper..
MT
09:53aGRITSTONE BIO : Oncology Doses First Volunteer in Phase 1 Trial of COVID-19 Vacc..
MT
07:58aASTRAZENECA : Credit Suisse remains its Buy rating
MD
07:56aASTRAZENECA : Buy rating from JP Morgan
MD
07:06aASTRAZENECA : Egypt Receives More Than 564k Doses of Covid-19 Vaccine Astrazenec..
AQ
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 247 M - -
Net income 2021 5 006 M - -
Net Debt 2021 24 250 M - -
P/E ratio 2021 31,0x
Yield 2021 2,54%
Capitalization 182 B 181 B -
EV / Sales 2021 5,86x
EV / Sales 2022 4,73x
Nbr of Employees 76 100
Free-Float 96,3%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 110,77 $
Average target price 136,00 $
Spread / Average Target 22,8%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC10.09%171 794
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.19.23%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604